Viral hepatitis and liver disease: proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD)
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Tokyo [u.a.]
Springer
1994
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XXII, 802 S. Ill., graph. Darst., Kt. |
| ISBN: | 354070132X 443170132X 038770132X |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV009610721 | ||
| 003 | DE-604 | ||
| 005 | 20160506 | ||
| 007 | t| | ||
| 008 | 940516s1994 xx abd| |||| 10||| eng d | ||
| 016 | 7 | |a 941100421 |2 DE-101 | |
| 020 | |a 354070132X |9 3-540-70132-X | ||
| 020 | |a 443170132X |9 4-431-70132-X | ||
| 020 | |a 038770132X |9 0-387-70132-X | ||
| 035 | |a (OCoLC)30032030 | ||
| 035 | |a (DE-599)BVBBV009610721 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 |a DE-20 |a DE-188 | ||
| 050 | 0 | |a RC848.H43 | |
| 082 | 0 | |a 616.3/6230194 |2 20 | |
| 084 | |a YC 5605 |0 (DE-625)153237:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Viral hepatitis and liver disease |b proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) |c ed. K. Nishioka ... |
| 264 | 1 | |a Tokyo [u.a.] |b Springer |c 1994 | |
| 300 | |a XXII, 802 S. |b Ill., graph. Darst., Kt. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 4 | |a Carcinoma, Hepatocellular |v Congresses | |
| 650 | 4 | |a Hepatitis Viruses |x physiology |v Congresses | |
| 650 | 4 | |a Hepatitis, Viral |v Congresses | |
| 650 | 4 | |a Hepatitis, Viral, Human |x diagnosis |v Congresses | |
| 650 | 4 | |a Hepatitis, Viral, Human |x epidemiology |v Congresses | |
| 650 | 4 | |a Hepatitis, Viral, Human |x therapy |v Congresses | |
| 650 | 0 | 7 | |a Leberkrankheit |0 (DE-588)4034937-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Virushepatitis |0 (DE-588)4290453-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hepatitisvirus |0 (DE-588)4261165-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1993 |z Tokio |2 gnd-content | |
| 689 | 0 | 0 | |a Virushepatitis |0 (DE-588)4290453-5 |D s |
| 689 | 0 | 1 | |a Leberkrankheit |0 (DE-588)4034937-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Virushepatitis |0 (DE-588)4290453-5 |D s |
| 689 | 1 | |5 DE-188 | |
| 689 | 2 | 0 | |a Hepatitisvirus |0 (DE-588)4261165-9 |D s |
| 689 | 2 | |5 DE-188 | |
| 689 | 3 | 0 | |a Leberkrankheit |0 (DE-588)4034937-8 |D s |
| 689 | 3 | |5 DE-188 | |
| 700 | 1 | |a Nishioka, Kusuya |e Sonstige |4 oth | |
| 711 | 2 | |a International Symposium on Viral Hepatitis and Liver Disease |n 8 |d 1993 |c Tokio |j Sonstige |0 (DE-588)2136686-X |4 oth | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006353025&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006353025 | |
Datensatz im Suchindex
| _version_ | 1816443141121638400 |
|---|---|
| adam_text |
CONTENTS
PROLOGUE:
HOW
FAR
HAVE
WE
COME?
WHAT
A
DUMB
WAY
TO
DESIGNATE
GERMS
H.J.
A
LTER
.
3
RECOLLECTIONS
OF
A
HEPATITIS
INVESTIGATOR:
1940-1993
S.
K
RUGMAN
.
5
THE
HEPATITIS
VIRUSES:
ACCOMPLISHMENTS
AND
PROBLEMS
B.S.
B
LUMBERG
.
7
HOW
FAR
HAVE
WE
COME,
AND
WHERE
ARE
WE
GOING?
3
YEARS
AFTER
1990
F.B.
H
OLLINGER
.
10
HOW
FAR
HAVE
WE
COME
AND
WHERE
ARE
WE
GOING?:
PATHOGEN-ORIENTED
PREVENTION
OF
HEPATOCELLULAR
CARCINOMA
IN
JAPAN
IN
1993
K.
N
ISHIOKA
.
12
HEPATITIS
VIRUSES
A,
B,
C,
D,
&
E
1.
PERSPECTIVES
THE
HEPATITIS
VIRUSES:
AN
OVERVIEW
R.H.
P
URCELL
.
19
RECENT
ADVANCES
IN
UNDERSTANDING
THE
MOLECULAR
VIROLOGY
OF
HEPATOVIRUSES:
CONTRASTS
AND
COMPARISONS
WITH
HEPATITIS
C
VIRUS
S.M.
L
EMON
,
L.E.
W
HETTER
,
K.H.
C
HANG
,
AND
E.A.
B
ROWN
.
22
HEPATOCARCINOGENIC
MECHANISMS
IN
HEPADNAVIRUS-INFECTED
HOSTS
W.S.
R
OBINSON
.
28
THE
HEPATITIS
C
VIRUS:
GENETIC
ORGANIZATION,
PERSISTENCE,
AND
VACCINE
STRATEGIES
M.
H
OUGHTON
,
Q.-L.
C
HOO
,
G.
K
UO
,
R.
R
ALSTON
,
M.
S
ELBY
,
A.
W
EINER
,
D.
C
HIEN
,
J.
H
AN
,
C.
W
ALKER
,
S.
A
BRIGNANI
,
M.
K
OZIEL
,
B.
W
ALKER
,
L.
C
UMMINS
,
AND
E.
M
UCHMORE
.
33
THE
MOLECULAR
BIOLOGY
OF
HEPATITIS
DELTA
VIRUS:
RECENT
ADVANCES
J.L.
G
ERIN
,
J.L.
C
ASEY
,
AND
K.F.
B
ERGMANN
.
38
MOLECULAR
AND
SEROLOGICAL
CHARACTERISTICS
OF
HEPATITIS
E
VIRUS
D.W.
B
RADLEY
AND
M.
A.
P
URDY
.
42
X
CONTENTS
2.
TAXONOMY
CLASSIFICATION
AND
TAXONOMY
OF
HEPATITIS
VIRUSES:
SUMMARY
OF
A
WORKSHOP
J.L.
M
ELNICK
AND
C.R.
H
OWARD
.
47
TAXONOMIC
CLASSIFICATION
OF
HEPATITIS
A
VIRUS
S.M.
L
EMON
AND
B.H.
R
OBERTSON
.
50
CLASSIFICATION
AND
TAXONOMY
OF
THE
HEPADNAVIRUSES:
CURRENT
STATUS
C.R.
H
OWARD
.
54
DERIVATION
OF
A
RATIONAL
NOMENCLATURE
FOR
HEPATITIS
C
VIRUS
BY
PHYLOGENETIC
ANALYSIS
OF
THE
NS-5
REGION
E.C.
H
OLMES
,
P.
S
IMMONDS
,
T.-A.
C
HA
,
S.-W.
C
HAN
,
F.
M
C
O
MISH
,
B.
I
RVINE
,
E.
B
EALL
,
P.L.
Y
AP
,
J.
K
OLBERG
,
AND
M.S.
U
RDEA
.
57
THE
TAXONOMY
OF
HEPATITIS
DELTA
VIRUS
J.L.
G
ERIN
.
63
HEPATITIS
E
VIRUS:
SOME
CHARACTERISTICS
RELEVANT
TO
VIRUS
CLASSIFICATION
M.S.
B
ALAYAN
.
65
NEW
HEPATITIS
VIRUS(ES)?
NEW
AGENT(S)
TO
CAUSE
HEPATITIS?:
SUMMARY
OF
A
SPECIALTY
SESSION
S.M.
F
EINSTONE
AND
T.
M
IYAMURA
.
71
CANDIDATE
HEPATITIS
F
VIRUS
IN
SPORADIC
NON-A,
NON-B
ACUTE
LIVER
FAILURE:
EXCLUSION
IN
LIVER
OF
HEPATITIS
VIRUSES
A,
E,
C
AND
B
BY
POLYMERASE
CHAIN
REACTION
E.A.
F
AGAN
ANDT.J.
H
ARRISON
.
73
NON-A,
NON-B,
NON-C,
NON-E
ACUTE
HEPATITIS:
DOES
IT
REALLY
EXIST?
M.
B
UTI
,
R.
J
ARDI
,
F.
R
ODRIGUEZ
-F
RIAS
,
J.
Q
UER
,
R.
E
STEBAN
,
AND
J.
G
UARDIA
.
77
CLINICAL
AND
LABORATORY
FEATURES
OF
ACUTE
COMMUNITY-ACQUIRED
NON-A,
NON-B,
NON-C
HEPATITIS
N.C.
T
ASSOPOULOS
,
A.
H
ATZAKIS
,
M.
K
UHNS
,
V.
M
IRIAGOU
,
I.
D
ELLADETSIMA
,
M.G.
K
OUTELOU
,
G.
T
OULOUMI
,
G.V.
P
APATHEODORIDIS
,
J.
C
HRISPEELS
,
H.
T
ROONEN
,
AND
D.
T
RICHOPOULOS
.
80
CHRONIC
NON-A,
NON-B,
NON-C
HEPATITIS
IN
FRENCH
BLOOD
DONORS
ASSESSED
WITH
HCV
THIRD-GENERATION
TESTS
AND
POLYMERASE
CHAIN
REACTION
P.
M
ARCELLIN
,
M.
M
ARTINOT
-P
EIGNOUX
,
F.
G
ABRIEL
,
M.
B
RANGER
,
A.
E
LIAS
,
C.
D
EGOTT
,
P.
A
UMONT
,
S.
E
RLINGER
,
AND
J.P.
B
ENHAMOU
.
85
EVIDENCE
FOR
PARENTERALLY
TRANSMITTED
NON-A,
NON-B,
NON-C,
NON-D,
NON-E
HEPATITIS
IN
RUSSIA
M.O.
F
AVOLOV
,
O.O.
Z
NOIKO
,
T.L.
Y
ASHINA
,
P.
P
ATEL
,
E.Z.
G
OLDBERG
,
Y.E.
K
HUDYAKOV
,
B.
K
HANNA
,
H.A.
F
IELDS
,
E.P.
G
ORBARETS
,
V.I.
K
ASHIRIN
,
AND
H.S.
M
ARGOLIS
.
87
BIOLOGY
MOLECULAR
BIOLOGY
OF
HEPATITIS
B
VIRUS
K.
M
ATSUBARA
.
91
EXPRESSION
OF
DEFECTIVE
HEPATITIS
B
(HBV)-DNA,
SYNTHESIZED
FROM
A
SINGLY
SPLICED
HBV-RNA,
LEADS
TO
CYTOPLASMIC
ACCUMULATION
OF
CAPSID
AND
X
PROTEINS
O.
R
OSMORDUC
,
M.A.
P
ETIT
,
F.
C
APEL
,
M.
W
EBER
,
C.
B
R
S
CHOT
,
AND D.
K
REMSDORF
.
92
METHODS
FOR
THE
PURIFICATION
OF
ENZYMATICALLY
ACTIVE
REVERSE
TRANSCRIPTASE
OF
DUCK
HEPATITIS
B
VIRUS
F.
Z
OULIM
,
G.-H.
W
ANG
,
AND
C.
S
EEGER
.
97
CONTENTS
XI
SOME
ASPECTS
OF
HEPATITIS
C
VIRUS:
A
REVIEW
AND
A
HYPOTHESIS
H.
Y
OSHIKURA
,
M.
H
IJIKATA
,
AND
Y.K.
S
HIMIZU
.
101
IN
VIVO
AND
IN
VITRO
REPLICATION,
EXPRESSION,
PROCESSING,
AND
ASSEMBLY
OF
HEPATITIS
C
VIRUS:
SUMMARY
OF
A
SPECIALITY
SESSION
E.
A.
B
ROWN
,
H.
O
KAYAMA
,
AND
S.M.
L
EMON
.
104
MOLECULAR
BIOLOGY
OF
PESTIVIRUSES
AND
COMPARISON
WITH
HCV
G.
M
EYERS
,
R.
S
TARK
,
N.
T
AUTZ
,
T.
R
UMENAPF
,
G.
U
NGER
,
AND
H.-J.
T
HIEL
.
106
VIRUS-LIKE
PARTICLES
IN
THE
LIVER
OF
AN
OWL
MONKEY
INOCULATED
WITH
HEPATITIS
C
VIRUS
L.
A
SHER
,
W.
P
ARLETT
,
J.
E
GAN
,
S.
P
OLO
,
AND
R.
B
AUMGARTNER
.
ILL
USEFUL
MARKERS
FOR
PREDICTING
IN
VIVO
INFECTIVITY
OF
HEPATITIS
C
VIRUS
Y.K.
S
HIMIZU
,
M.
H
IJIKATA
,
A.
I
WAMOTO
,
R.H.
P
URCELL
,
AND
H.
Y
OSHIKURA
.
115
HCV-SPECIFIC
TRANSLATION
INITIATION
A.
N
OMOTO
,
K.
T
SUKIYAMA
-K
OHARA
,
AND
M.
K
OHARA
.
118
TRANSLATION
INITIATION
MECHANISM
ON
HEPATITIS
C
VIRUS
RNA
K.
T
SUKIYAMA
-K
OHARA
,
M.
K
OHARA
,
AND
A.
N
OMOTO
.
121
MAPPING
OF
THE
INTERNAL
RIBOSOME
ENTRY
SITE
AT
THE
5'
END
OF
THE
HEPATITIS
C
VIRUS
GENOME
H.
K
ETTINEN
,
K.
G
RACE
,
S.
G
RUNERT
,
B.
C
LARKE
,
D.
R
OWLANDS
,
AND
R.
J
ACKSON
.
125
SECONDARY
STRUCTURE
AND
PROTEIN-BINDING
ACTIVITIES
OF
THE
5'
NONTRANSLATED
REGION
OF
THE
HEPATITIS
C
VIRUS
GENOME
K.H.
C
HANG
,
E.A.
B
ROWN
,
AND
S.M.
L
EMON
.
132
HEPATITIS
C
VIRUS
POLYPROTEIN
PROCESSING
A.
G
RAKOUI
,
D.W.
M
C
C
OURT
,
C.
W
YCHOWSKI
,
C.
L
IN
,
S.M.
F
EINSTONE
,
AND
C.M.
R
ICE
.
136
PROCESSING
MECHANISMS
OF
NONSTRUCTURAL
PROTEINS
OF
HEPATITIS
C
VIRUS
M.
H
IJIKATA
,
H.
M
IZUSHIMA
,
Y.
T
ANJI
,
Y.
K
OMODA
,
Y.
H
IROWATARI
,
T.
A
KAGI
,
N.
K
ATO
,
T.
T
ANAKA
,
K.
K
IMURA
,
AND
K.
S
HIMOTOHNO
.
140
IMMUNOELECTRON
MICROSCOPIC
LOCALIZATION
OF
PROCESSED
CORE
PROTEIN
OF
HEPATITIS
C
VIRUS
IN
COS
CELLS
G.
Y
AMADA
,
M.
M
IZUNO
,
M.
T
AKATANI
,
F.
K
ISHI
,
T.
D
OI
,
R.
M
IYAMOTO
,
T.
T
SUJI
,
R.R.
L
ESNIEWSKI
,
H.
Y
OSHIZAWA
,
AND
K.
S
HIMOTOHNO
.
144
THE
PHYSICAL
STATE
OF
THE
NEGATIVE
STRAND
OF
HEPATITIS
C
VIRUS
RNA
IN
SERUM
M.
S
HINDO
,
A.
D
I
B
ISCEGLIE
,
T.
A
KATSUKA
,
T.-L.
F
ONG
,
M.
D
ONETS
,
J.H.
H
OOFNAGLE
,
AND
S.M.
F
EINSTONE
.
147
IMMUNOLOGY
AND
PATHOGENESIS
I.
IMMUNOPATHOGENESIS
CELLULAR
IMMUNE
RESPONSES
TO
HEPATITIS
VIRUSES:
SUMMARY
OF
A
SPECIALTY
SESSION
T.
T
SUJI
AND
F.
V.
C
HISARI
.
153
STUDIES
OF
CYTOTOXIC
T
LYMPHOCYTE
ACTIVITY
IN
TAMARINS
WITH
ACUTE
HEPATITIS
A
VIRUS
INFECTION
P.
K
ARAYIANNIS
,
S.
O
'
R
OURKE
,
J.
W
ATERS
,
R.
W
ATTS
,
AND
H.C.
T
HOMAS
.
155
ADOPTIVE
TRANSFER
OF
IMMUNITY
TO
HEPATITIS
B
THROUGH
BONE
MARROW
TRANSPLANTATION
FROM
IMMUNIZED
DONORS
Y.
I
LAN
,
A.
N
AGLER
,
R.
A
DLER
,
S.
S
LAVIN
,
AND
D.
S
HOUVAL
.
158
PEPTIDE
RECOGNITION
AND
COMPETITION,
T
CELL
RECEPTOR
USAGE,
AND
HLA
RESTRICTION
ELEMENTS
OF
T
CELL
CLONES
SPECIFIC
TO
A
DETERMINANT
OF
HEPATITIS
B
VIRUS
CORE
AND
E
ANTIGENS
IN
CHRONIC
TYPE
B
HEPATITIS
S.-L.
T
SAI
,
D.-S.
C
HEN
,
AND
T.-H.
C
HANG
.
162
XII
CONTENTS
A
METHOD
TO
DETECT
HEPATITIS
B
VIRUS-SPECIFIC
CYTOTOXIC
T
LYMPHOCYTES
IN
PATIENTS
WITH
ACUTE
AND
CHRONIC
HBV
INFECTION
G.
L
EROUX
-R
OELS
,
E.
V
AN
H
ECKE
,
J.
P
ARADIJS
,
C.
M
OLITOR
,
C.
B
ASTIN
,
P.
P
ALA
,
AND
M.
S
LAOUI
.
168
THE
ROLE
OF
THE
CYTOTOXIC
T
LYMPHOCYTES
RESPONSE
IN
HEPATITIS
B
VIRUS
IMMUNOBIOLOGY
AND
PATHOGENESIS
P.
F
OWLER
,
R.
N
AYERSINA
,
G.
M
ISSALE
,
A.
B
ERTOLETTI
,
A.
P
ENNA
,
K.
A
NDO
,
A.
C
ERNY
,
F.
F
IACCADORI
,
C.
F
ERRARI
,
AND
F.V.
C
HISARI
.
173
VARIABLE
REGION
USAGE
IN
T
LYMPHOCYTES
INFILTRATING
LIVER
TISSUES
OF
CHRONIC
LIVER
DISEASES
Y.
S
HIMIZU
,
T.
T
SUKISHIRO
,
K.
O
KADA
,
K.
A
OYAMA
,
K.
H
IGUCHI
,
AND
A.
W
ATANABE
.
178
IN
VITRO
IMMUNE
RESPONSES
SPECIFIC
FOR
NS3
REGIONAL
PEPTIDE
(C7)
AND
CORE REGIONAL
PEPTIDE
(CLL)
OF
HCV
IN
CHRONIC
HEPATITIS
C
H.
M
ORI
,
K.
Y
ABU
,
K.
Y
OSHIZAWA
,
S.
U
SUDA
,
E.
T
ANAKA
,
K.
K
IYOSAWA
,
A.
H
ASEGAWA
,
M.
K
OHARA
,
AND
S.
F
URUTA
.
182
RECOGNITION
OF
HEPATITIS
C
VIRUS
NUCLEOCAPSID
PROTEIN-DERIVED
PEPTIDES
BY
CYTOTOXIC
T
LYMPHOCYTES
H.
K
ITA
,
T.
M
ORIYAMA
,
T.
K
ANEKO
,
I.
H
ARASE
,
M.
N
OMURA
,
H.
M
IURA
,
I.
N
AKAMURA
,
Y.
Y
AZAKI
,
AND
M.
I
MAWARI
.
186
HEPATITIS
C
VIRUS-SPECIFIC
CYTOTOXIC
T
LYMPHOCYTES
RESTRICTED
BY
HLA-A2
ARE
PRESENT
IN
THE
PERIPHERAL
BLOOD
OF
PATIENTS
WITH
CHRONIC
HEPATITIS
C
A.
C
ERNY
,
J.G.
M
C
H
UTCHISON
,
C.
P
ASQUINELLI
,
M.A.
B
ROTHERS
,
P.
F
OWLER
,
M.
H
OUGHTON
,
AND
F.V.
C
HISARI
.
190
IN
VITRO
STUDIES
ON
THE
EFFECTS
OF
HEPATITIS
C
VIRUS
ON
HEMOPOIESIS
P.
B
OUFFARD
,
H.
S
CHUPPER
,
J.-H.
L
EE
,
K.
M
ACK
,
N.
L
EVY
,
R.
A
CEVEDO
,
AND
J.B.
Z
ELDIS
.
195
PATHOBIOLOGY
OF
FULMINANT
HEPATITIS
Y.
M
UTO
,
H.
O
HNISHI
,
M.
N
AGAKI
,
AND
K.
A
NDO
.
200
2.
HEPATITIS
C
VIRUS
AND
AUTOIMMUNITY
AUTOIMMUNE
HEPATITIS
M.P.
M
ANNS
.
205
HCV
IN
AUTOIMMUNE
AND
EXTRAHEPATIC
SYNDROMES:
SYNOPSIS
OF
A
SPECIALTY
SESSION
G.
T
ODA
AND
M.P.
M
ANNS
.
210
MECHANISMS
INVOLVED
IN
THE
PATHOGENESIS
OF
CRYOGLOBULINEMIA
IN
PATIENTS
WITH
CHRONIC
HAPATITIS
C
AND
OTHER
CAUSES
OF
CHRONIC
LIVER
DISEASES
F.
L
UNEL
,
L.
M
USSET
,
P.
C
ACOUB
,
M.
P
ERRIN
,
L.
F
RANGUEL
,
P.
G
ODEAU
,
P.
O
POLON
,
AND
J.M.
H
URAUX
.
213
CLINICAL,
IMMUNOLOGICAL,
AND
VIROLOGICAL
FEATURES
OF
HCV-ASSOCIATED
MEMBRANOPROLIFERATIVE
GLOMERULONEPHRITIS
D.R.
G
RETCH
,
R.J.
J
OHNSON
,
H.
Y
AMABE
,
M.H.
W
ENER
,
L.
C
OREY
,
C.
A
LPERS
,
AND
R.
W
ILLSON
.
218
IS
HEPATITIS
C
VIRUS
INFECTION
A
TRIGGER
OF
PORPHYRIA
CUTANEA
TARDA?
C.
H
ERRERO
,
A.
V
ICENTE
,
M.
B
RUGUERA
,
M.G.
E
RCILLA
,
J.M.
B
ARRERA
,
J.
V
IDAL
,
J.
T
ER
S
,
J.M.
M
ASCAR
6,
AND
J.
R
OD
S
S
.
222
CONTRIBUTION
OF
HEPATITIS
C
VIRUS
INFECTION
TO
THE
DEVELOPMENT
OF
SJOGREN
'
S
SYNDROME
IN
JAPAN
N.
M
ASAKI
,
S.
H
AYASHI
,
S.-I.
A
OTSUKA
,
AND
N.
U
MEDA
.
225
REACTIVITY
OF
SERA
FROM
JAPANESE
PATIENTS
WITH
TYPE
2
AUTOIMMUNE
HEPATITIS
TO
PEPTIDES
DERIVED
FROM
HOST
GENES,
CYTOCHROME HLD8-2 AND
GOR
H.
M
IYAKAWA
,
M.
K
AKO
,
S.
U
SUDA
,
AND
S.
M
ISHIRO
.
229
CONTENTS
XIII
GENETIC
VARIATION
OF
HEPATITIS
VIRUSES
1.
HBV
THE
MEANINGS
OF
MUTATIONS
IN
AND
AROUND
PRE-C/C
AND
PRE-S/S
REGIONS
OF
HBV:
SUMMARY
OF
A
SPECIALTY
SESSION
O.
Y
OKOSUKA
AND
F.
B
ONINO
.
235
GENETIC
AND
BIOLOGICAL
CHARACTERIZATION
OF
TWO
HAPATITIS
B
VIRUS
VARIANTS:
A
PRECORE
MUTANT
IMPLICATED
IN
FULMINANT
HEPATITIS
AND
A
SURFACE
MUTANT
RESISTANT
TO
IMMUNOPROPHYLAXIS
N.
O
GATA
,
R.H.
M
ILLER
,
K.G.
I
SHAK
,
A.R.
Z
ANETTI
,
AND
R.H.
P
URCELL
.
238
VACCINE-ASSOCIATED
MUTANTS
OF
HEPATITIS
B
VIRUS
W.F.
C
ARMAN
.
243
A
NOVEL
ANTIBODY
ESCAPE
VARIANT
(ALA
144)
OF
HEPATITIS
B
VIRUS
IN
AN
IDENTICAL
TWIN
BEFORE
SELECTION
IN
THE
MOTHER
T.J.
H
ARRISON
,
C.J.
O
ON
,
AND
A.J.
Z
UCKERMAN
.
248
HEPATITIS
B
VIRUS
VARIANTS
WITH
ALTERED
A
DETERMINANTS
CAUSING
INFECTIONS
IN
IMMUNIZED
CHILDREN
C.R.
H
OWARD
,
V.D.
K
ARTHIGESU
,
L.M.C.
A
LLISON
,
M.
F
ORTUIN
,
M.
M
ENDY
,
AND
H.C.
W
HITTLE
.
252
HEPATITIS
B
VIRUS
PRECORE
MUTANTS
F.
B
ONINO
AND
M.R.
B
RUNETTO
.
256
WILD-TYPE
AND
HBEAG-MINUS
HBV
FLUCTUATIONS:
CAUSE
OR
EFFECT
OF
CHRONIC
HEPATITIS
B
PATHOGENIC
MECHANISMS?
M.R.
B
RUNETTO
,
G.
C
APRA
,
A.
R
ANDONE
,
P.
C
ALVO
,
C.
B
ARBERA
,
G.
S
ARACCO
,
F.
O
LIVERI
,
L.
M
ICHIELETTO
,
M.
D
'
A
CQUINO
,
P.
P
IANTINO
,
M.
R
ANKI
,
G.
V
ERME
,
AND
F.
B
ONINO
.
261
NUCLEOTIDE
SEQUENCE
ANALYSIS
OF
THE
PRECORE
REGION
IN
PATIENTS
WITH
FULMINANT
HEPATITIS
B
IN
THE
USA
T.
L
ASKAS
,
D.H.
P
ERSING
,
M.
N
OWICKI
,
J.W.
M
OSLEY
,
AND
J.
R
AKELA
.
265
BASE
PAIRING
IN
THE
PREGENOME
ENCAPSIDATION
SIGNAL
OF
HBV:
A
CLUE
FOR
THE
PREVALENCE
OF
NATURALLY
OCCURRING
HBEAG-MINUS
PRECORE
MUTATIONS
S.-P.
T
ONG
,
J.-S.
L
I
,
L.
V
ITVITSKI
,
A.
K
AY
,
AND
C.
T
R
E
PO
.
269
CORE
PROTEIN
EVOLUTION
AFTER
SELECTION
OF
HEPATITIS
B
PRECORE
MUTANTS
AND
CORRELATION
WITH
DISEASE
SEVERITY
W.F.
C
ARMAN
,
G.
M
C
I
NTYRE
,
S.
H
ADZIYANNIS
,
G.
F
ATTOVICH
,
A.
A
LBERTI
,
AND
H.C.
T
HOMAS
.
273
MUTATIONS
IN
THE
CORE
NUCLEOTIDE
SEQUENCE
OF
HEPATITIS
B
VIRUS
CORRELATE
WITH
SEVERE
LIVER
DAMAGE
T.
E
HATA
,
M.
O
MATA
,
W.-L.
C
HUANG
,
O.
Y
OKOSUKA
,
Y.
I
TO
,
K.
H
OSODA
,
AND
M.
O
HTO
.
277
2.
HCV
DIVERSITY
OF
THE
CLASSIFICATION
AND
NOMENCLATURE
SYSTEMS
FOR
HEPATITIS
C
VIRUS
GENOTYPES:
A
PROPOSED
SOLUTION
TO
THE
PRESENT
CONFUSION
S.
M
ISHIRO
AND
D.
B
RADLEY
.
283
THE
MOLECULAR
DIVERSITY
OF
HEPATITIS
C
VIRUS
AND
ITS
CLINICAL
SIGNIFICANCE:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
G.
D
USHEIKO
AND
S.
I
INO
.
286
MOLECULAR
EVOLUTIONARY
CLASSIFICATION
OF
HEPATITIS
C
VIRUSES
AND
THEIR
DIVERGENCE
TIMES
M.
M
IZOKAMI
,
K.-I.
O
HBA
,
Y.
I
NA
,
E.
O
RITO
,
K.
S
UZUKI
,
T.
O
HNO
,
AND
T.
G
OJOBORI
.
292
SEQUENCE
ANALYSIS
OF
THE
5'
NONCODING
REGION REVEALS
THE
EXISTENCE
OF
MULTIPLE
HEPATITIS
C
VIRUS
GENOTYPES
IN
QUEBEC,
CANADA
D.G.
M
URPHY
,
B.
W
ILLEMS
,
J.-P.
V
ILLENEUVE
,
AND
G.
D
ELAGE
.
296
XIV
CONTENTS
HEPATITIS
C
VIRUS
GENOTYPES:
AN
INVESTIGATION
OF
TYPE-SPECIFIC
DIFFERENCES
IN
GEOGRAPHIC
ORIGIN
AND
DISEASE
G.
D
USHEIKO
,
H.
S
CHMILOVITZ
-W
EISS
,
D.
B
ROWN
,
F.
M
C
O
MISH
,
P.-L.
Y
AP
,
S.
S
HERLOCK
,
N.
M
C
I
NTYRE
,
AND
P.
S
IMMONDS
.
301
A
DISTINCT
GENETIC
GROUP
OF
HEPATITIS
C
VIRUS
CIRCULATING
WITHIN
THE
FORMER
SOVIET
UNION
B.H.
R
OBERTSON
,
B.
K
HANNA
,
M.O.
F
AVOROV
,
T.
Y
ASHINA
,
AND
T.
T
RETSKAYA
.
306
SEQUENCE
ANALYSIS
OF
HEPATITIS
C
VIRUS
OBTAINED
FROM
INDONESIAN
PATIENTS
AND
IDENTIFICATION
OF
NOVEL
SEQUENCE
VARIANTS
H.
H
OTTA
,
H.
D
OI
,
T.
H
AYASHI
,
M.
P
URWANTA
,
M.I.
L
USIDA
,
W.
S
OEMARTO
,
AND
M.
H
OMMA
.
310
LOW
PREVALENCE
OF
ANTI-EL
ANTIBODIES
REACTIVE
TO
RECOMBINANT
TYPE
LB
EL
ENVELOPE
PROTEIN
IN
TYPE
2,
3,
AND
4
HCV
SERA,
BUT
HIGH
PREVALENCE
IN
SUBTYPES
LA
AND
LB
G.
M
AERTENS
,
A.
D
UCATTEEUW
,
L.
S
TUYVER
,
P.
V
ANDEPONSEELE
,
A.
V
ENNEMAN
,
A.
W
YSEUR
,
F.
B
OSMAN
,
R.
H
EIJTINK
,
AND
G.
DE
M
ARTYNOFF
.
314
THE
USE
OF
A
LINE
PROBE
ASSAY
AS
A
TOOL
TO
DETECT
NEW
TYPES
OR
SUBTYPES
OF
THE
HAPATITIS
C
VIRUS
L.
S
TUYVER
,
A.
W
YSEUR
,
W.
V
AN
A
RNHEM
,
R.
R
OSSAU
,
E.
D
ELAPORTE
,
M.-C.
D
AZZA
,
L.-J.
V
AN
D
OORN
,
B.
K
LETER
,
B.
V
ANDERBORGHT
,
C.
Y
OSHIDA
,
AND
G.
M
AERTENS
.
317
DISTINCT
SUBTYPES
OF
HEPATITIS
C
VIRUS
DEFINED
BY
ANTIBODIES
DIRECTED
TO
THE
PUTATIVE
CORE,
NS4,
AND
NS5
REGION
POLYPEPTIDES
D.Y.
C
HIEN
,
J.
M
C
F
ARLAND
,
A.
T
ABRIZI
,
C.
K
UO
,
M.
H
OUGHTON
,
AND
G.
KUO
.
320
SEQUENCING
AND
GENOTYPING
OF
HEPATITIS
C
VIRUS
IN
PATIENTS
WITH
AUTOIMMUNE
HEPATITIS
TYPE
2
K.
M
ICHITAKA
,
M.
D
URAZZO
,
H.L.
T
ILLMAN
,
D.
W
ALKER
,
T.
P
HILIPP
,
AND
M.P.
M
ANNS
.
325
HEPATITIS
C
VIRUS
HYPERVARIABLE
REGION
MAY
CONFER
ESCAPE
FROM
IMMUNOSURVEILLANCE
N.
K
ATO
,
H.
S
EKIYA
,
T.
N
AKAZAWA
,
K.
Y
AMAUCHI
,
S.
O
HKOSHI
,
T.
G
UNJI
,
M.
H
IJIKATA
,
AND
K.
S
HIMOTOHNO
.
329
DIAGNOSIS
1.
HCV
NEW
METHODS
FOR
HCV
DIAGNOSIS:
SUMMARY
OF
A
SPECIALTY
SESSION
Y.
F
URUICHI
AND
L.R.
O
VERBY
.
337
CURRENT
AND
FUTURE
STATUS
OF
HEPATITIS
C
VIRUS
DIAGNOSIS:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
K.
F
UJISAWA
.
339
ANTIBODY
PROFILE
OF
BLOOD
DONORS
INFECTED
WITH
HEPATITIS
C
VIRUS
H.
S
HIRAKI
,
C.
I
SHIDA
,
K.
M
ATSUMOTO
,
K.
F
UKADA
,
K.
M
ATSUSHITA
,
AND
Y.
M
AEDA
.
341
RECOMBINANT
PROTEINS
AND
SYNTHETIC
PEPTIDES
CONTAINING ANTIGENIC
EPITOPES
OF
THE
HEPATITIS
C
VIRUS
PROTEINS
AND
DEVELOPMENT
OF
A
NEW
DIAGNOSTIC
TEST
FORMAT
H.A.
F
IELDS
,
Y.
K
HUDYAKOV
,
M.-T.
B
ONAFONTE
,
N.
K
HUDYAKOVA
,
M.O.
F
AVOROV
,
D.
J
UE
,
AND
H.S.
M
ARGOLIS
.
346
EARLIER
DETECTION
OF
ANTI-HCV
SEROCONVERSION
IN
POST-TRANSFUSION
NANBH
BY
A
PROTOTYPE
HCV
3.0
ELISA
J.M.
B
ARRERA
,
M.G.
E
RCILLA
,
B.
F
RANCIS
,
M.
N
ELLES
,
AND
S.R.
L
EE
.
350
BLOOD
SCREENING
FOR
ASYMPTOMATIC
HEPATITIS
C
VIRUS
CARRIERS
WITH
SECOND-GENERATION
HEPATITIS
C
VIRUS
ANTIBODY
ASSAYS
N.
Y
UKI
,
N.
H
AYASHI
,
H.
H
AGIWARA
,
K.
O
HKAWA
,
A.
K
ASAHARA
,
H.
F
USAMOTO
,
S.
O
HTANI
,
Y.
O
KUBO
,
AND
T.
K
AMADA
.
352
AN
AUTOMATED
DIAGNOSTIC
ASSAY
FOR
HCV
S.
M
ADAUS
,
S.
K
RAMER
,
T.
W
RIGHT
,
C.
F
LYNN
,
AND
D.
R
OBBINS
.
355
CONTENTS
XV
REPLICATIVE
LEVEL
OF
HCV
DETERMINED
BY
THE
COMPETITIVE
REVERSE
TRANSCRIPTION
AND
POLYMERASE
CHAIN
REACTION
ASSAY
IN
VARIOUS
STAGES
OF
CHRONIC
HCV
INFECTION
H.
H
AGIWARA
,
N.
H
AYASHI
,
M.
N
AITO
,
E.
M
ITA
,
A.
K
ASAHARA
,
H.
F
USAMOTO
,
AND
T.
K
AMADA
.
357
THREE-BAND
NESTED
DOUBLE
PCR
FOR
SEMIQUANTITATION
OF
HEPATITIS
C
VIRUS
IN
DONATED
BLOOD:
COMPARISON
WITH
ANTIBODY
AND
ALANINE
AMINOTRANSFERASE
LEVEL
C.
M
ATSUMOTO
,
Y.
M
ITOMI
,
J.
W
ATANABE
,
AND
K.
N
ISHIOKA
.
361
2.
HEV
DIAGNOSIS
AND
EPIDEMIOLOGY
OF
HEV:
SUMMARY
OF
A
SPECIALTY
SESSION
I.K.
M
USHAHWAR
AND
T.
U
CHIDA
.
365
ASSAY
DEVELOPMENT
OF
DIAGNOSTIC
TESTS
FOR
HEPATITIS
E
P.O.
Y
ARBOUGH
,
A.W.
T
AM
,
K.
G
ABOR
,
E.
G
ARZA
,
R.A.
M
OECKLI
,
I.
P
ALINGS
,
C.
S
IMONSEN
,
AND
G.R.
R
EYES
.
367
RECOMBINANT
ANTIGENS
AND
SYNTHETIC
PEPTIDES
FOR
SERODIAGNOSIS
OF
HEPATITIS
E
VIRUS
INFECTION
G.
D
AWSON
,
D.
P
AUL
,
R.
G
UTIERREZ
,
T.
P
ILOT
-M
ATIAS
,
K.
C
HAU
,
C.
K
YRK
,
S.
B
UIJK
,
M.
K
NIGGE
,
C.
H
EYNEN
,
T.
L
EUNG
,
C.
C
ABAL
,
AND
I.K.
M
USHAHWAR
.
371
HEPATITIS
E
AMONG
REFUGEES
IN
KENYA:
MINIMAL
APPARENT
PERSON-TO-PERSON
TRANSMISSION,
EVIDENCE
FOR
AGE-DEPENDENT
DISEASE
EXPRESSION,
AND
NEW
SEROLOGIC
ASSAYS
E.E.
M
AST
,
L.B.
P
OLISH
,
M.O.
F
AVOROV
,
N.S.
K
HUDYAKOVA
,
C.
C
OLLINS
,
P.M.
T
UKEI
,
D.
K
OPTICH
,
Y.E.
K
HUDYAKOV
,
H.A.
F
IELDS
,
H.S.
M
ARGOLIS
,
AND
THE
S
OMALI
R
EFUGEE
M
EDICAL
T
EAM
.
375
EPIDEMIOLOGY
1.
GLOBAL
PERSPECTIVES
VIRAL
HEPATITIS
IN
AFRICA
IN
THE
90S:
FACING
REALITIES
E.A.
A
YOOLA
.
381
VIRAL
HEPATITIS
IN
ASIA:
SUMMARY
OF
A
PLENARY
SESSION
H.
S
UZUKI
AND
G.
W
OODFIELD
.
385
HEPATITIS
IN
THE
SOUTH
PACIFIC
G.
W
OODFIELD
.
387
GLOBAL
PERSPECTIVE
OF
VIRAL
HEPATITIS
AND
LIVER
DISEASE:
THE
WESTERN
PACIFIC
I.D.
G
UST
.
390
HEPATITIS
IN
INDONESIA
H.A.
S
ULAIMAN
.
394
VIRAL
HEPATITIS
IN
INDIA
B.N.
T
ANDON
,
S.K.
A
CHARYA
,
S.
D
ASARATHY
,
AND
A.
T
ANDON
.
397
VIRAL
HEPATITIS
IN
THE
PHILIPPINES:
A
PERSPECTIVE
E.
D
OMINGO
,
M.A.
L
ANGSANG
,
B.
R
AMIREZ
,
M.
A
RGUILLAS
,
F.
V
INCULADO
,
L.
C
AVINTA
,
AND
M.
M
ONTEJO
.
400
PERSPECTIVE
OF
VIRAL
HEPATITIS
IN
THAILAND
T.
C
HAINUVATI
.
403
ETIOLOGY
OF
CHRONIC
LIVER
DISEASE
IN
NEPAL
S.
S
HRESTHA
.
406
EPIDEMIOLOGY
OF
HEPATITIS
E
VIRUS
(HEV):
A
COHORT
STUDY
IN
KATHMANDU,
NEPAL
C.F.
L
ONGER
,
M.P.
S
HRESTHA
,
P.O.
M
AC
A
RTHY
,
K.S.A.
M
YINT
,
C.H.
H
OKE
J
R
,
J.
T
ICEHURST
,
AND
B.L.
I
NNIS
.
409
EPIDEMIOLOGY
OF
HEPATITIS
B
AND
C
IN
CHINA
Q.-M.
T
AO
,
Y.
W
ANG
,
S.-C.
D
U
,
AND
J.-P.
GUO
.
412
XVI
CONTENTS
PREVALENCE
OF
HEPATITIS
C
VIRUS
INFECTION
IN
NANJING,
SOUTHERN
CHINA
K.
S
UZUKI
,
M.
M
IZOKAMI
,
X.-S.
W
U
,
R.-R.
W
U
,
Z.-X.
F
ANG
,
L.-Y.
Z
HANG
,
AND
S.
I
INO
.
416
VIRAL
HEPATITIS
IN
TAIWAN:
STATUS
IN
THE
1990S
Y.-F.
L
IAW
.
419
RELATIVE
ETIOLOGIC
ROLE
OF
HEPATITIS
B
VIRUS
AND
HEPATITIS
C
VIRUS
IN
CHRONIC
LIVER
DISEASES
AMONG
AGE-SPECIFIC
GROUPS
IN
KOREA
C.Y.
K
IM
,
H.-S.
L
EE
,
AND
C.J.
H
AN
.
422
VIRAL
HEPATITIS
IN
JAPAN
H.
S
UZUKI
.
426
VIRAL
HEPATITIS
IN
THE
FORMER
SOVIET
UNION
D.K.
LVOV
.
429
A
SEROPREVALENCE
STUDY
OF
HEPATITIS
E
IN
EUROPE
AND
THE
MIDDLE
EAST
A.
R
ITTER
,
H.
F
LACKE
,
A.
V
ORNWALD
,
H.
Z
AAIJER
,
A.A.
S
AEED
,
G.
D
AWSON
,
B.
S
IMPSON
,
AND
R.
S
UTHERLAND
.
432
PERSPECTIVES
ON
VIRAL
HEPATITIS
ELIMINATION
IN
EUROPE
G.
P
APAEVANGELOU
.
435
VIRAL
HEPATITIS
IN
NORTH
AMERICA
M.J.
A
LTER
,
C.N.
S
HAPIRO
,
P.J.
C
OLEMAN
,
AND
H.S.
M
ARGOLIS
.
439
2.
MODE
OF
TRANSMISSION
TRANSMISSION
PATTERNS
IN
HEPATITIS
C
VIRUS
INFECTION
H.J.
A
LTER
.
445
HEPATITIS
C
VIRUS
INFECTIONS
IN
U.S.
FAMILIES
T.W.
M
C
G
OVERN
,
K.C.
H
OLTZMULLER
,
K.E.
S
HERMAN
,
M.A.
S
MITH
,
S.C.
K
ADAKIA
,
T.
K
EPCZYK
,
K.L.
I
NSCOE
,
J.
M
URPHY
,
A.F.
S
EE
,
E.R.
M
ORRIS
,
R.H.K.
W
ONG
,
AND
M.H.
S
JOGREN
.
450
SEXUAL
TRANSMISSION
OF
HEPATITIS
C
VIRUS
T.
O
HNO
,
M.
M
IZOKAMI
,
J.Y.N.
L
AU
,
Y.
I
NA
,
E.
O
RITO
,
K.
S
UZUKI
,
K.
O
HBA
,
N.
M
IZOGUCHI
,
AND
T.
G
OJOBORI
.
455
TRANSMISSION
OF
HEPATITIS
C
VIRUS
THROUGH
NEEDLESTICK
ACCIDENTS
IN
HEALTH
CARE
WORKERS
T.
S
ODEYAMA
,
K.
K
IYOSAWA
,
A.
U
RUSHIHARA
,
A.
M
ATSUMOTO
,
E.
T
ANAKA
,
S.
F
URUTA
,
M.
M
IZOKAMI
,
AND
Y.
A
KAHANE
.
459
HCV-POSITIVE,
HIV-L-NEGATIVE
MOTHERS
TRANSMIT
HCV
A.J.
W
EINER
,
M.M.
T
HALER
,
K.
C
RAWFORD
,
J.
K
ANSOPON
,
K.
C
HING
,
J.E.
H
ALL
,
F.
H
U
,
D.
C
HIEN
,
AND
M.
H
OUGHTON
.
463
PROSPECTIVE
STUDY
OF
MOTHER-TO-INFANT
TRANSMISSION
OF
HEPATITIS
C
VIRUS
I.
N
AGATA
,
T.
I
IZUKA
,
Y.
H
ARADA
,
T.
O
KADA
,
R.
M
ATSUDA
,
Y.
T
ANAKA
,
K.
T
ANIMOTO
,
AND
K.
S
HIRAKI
.
468
SERIAL
FOLLOW-UP
OF
HEPATITIS
C
VIRUS
RNA
AND
ANTIBODY
IN
INFANTS
BORN
TO
HEPATITIS
C
VIRUS
POSITIVE
BUT
HUMAN
IMMUNODEFICIENCY
VIRUS
NEGATIVE
MOTHERS
Y.-H.
NI,
H.-H.
L
IN
,
P.-J.
C
HEN
,
H.-Y.
H
SU
,
D.-S.
C
HEN
,
C.-Y.
L
EE
,
AND
M.-H.
C
HANG
.
471
MOTHER-TO-INFANT
TRANSMISSION
OF
HEPATITIS
C
VIRUS:
A
PROSPECTIVE
STUDY
M.G.
E
RCILLA
,
C.
F
ORTUNY
,
A.
R
OCA
,
R.
C
ELIS
,
O.
C
OLL
,
A.
T
ORN
,
C.
G
IL
,
M.
B
RUGUERA
,
J.M.
B
ARRERA
,
R.
J
IMENEZ
,
AND
J.
ROOTS
.
474
3.
HIGH-RISK
GROUPS
HEPATITIS
C
VIRUS
INFECTION
IN
HEALTH
CARE
WORKERS
K.
K
IYOSAWA
,
T.
S
ODEYAMA
,
E.
T
ANAKA
,
AND
S.
F
URUTA
.
479
EVIDENCE
OF
HCV
INFECTION
BY
MEANS
OF
RIBA
IN
A
POPULATION
OF
DRUG
ABUSERS
L.
F
RUTTALDO
,
G.
S
CHETTINO
,
M.
C
OCCOLI
,
P.
G
IANNINI
,
AND
F.
M
ONGI
P
.
483
CONTENTS
XVII
SEROLOGICAL
RESPONSE
TO
HEPATITIS
C
VIRUS
(HCV)
IN
SERIAL
BLEEDS
FROM
HEMODIALYSIS
PATIENTS
E.
G
UERRERO
,
A.
G
UERRERO
,
L.
G
IL
,
R.
M
ONTES
,
J.
M
ATEOS
,
M.
C
UNNINGHAM
,
D.
V
ALLARI
,
J.
C
ASEY
,
S.
W
ATANABE
,
B.
Z
ECK
,
S.
D
ESAI
,
AND
S.
D
EVARE
.
485
HEPATITIS
C
VIRUS
RNA
IN
ANTI-HCV-POSITIVE
HEMODIALYZED
PATIENTS:
SIGNIFICANCE
AND
THERAPEUTIC
IMPLICATIONS
S.
P
OL
,
R.
R
OMEO
,
B.
Z
INS
,
F.
D
RISS
,
B.
L
EBKIRI
,
F.
C
ARNOT
,
P.
B
ERTHELOT
,
AND
C.
B
R
S
CHOT
.
489
HEPATITIS
C
AFTER
KIDNEY
TRANSPLANTATION
T.
P
ETERS
,
W.
G
ROTZ
,
F.
S
CHEIFFELE
,
H.
B
ERTHOLD
,
P.
S
CHOLLMEYER
,
AND
J.
R
ASENACK
.
491
PREVENTION
1.
OVERVIEWS
PREVENTION
A.M.
P
RINCE
AND
K.
N
ISHIOKA
.
499
STRATEGIES
FOR
THE
DEVELOPMENT
OF
HEPATITIS
C
AND
E
VACCINE:
SUMMARY
OF
A
BREAKFAST
WORKSHOP
T.
S
HIKATA
.
501
NEW
HEPATITIS
A
AND
B
VACCINES:
SUMMARY
OF
A
SPECIALTY
SESSION
M.R.
H
ILLEMAN
AND
Y.
M
ORITSUGU
.
503
A
NEW
VACCINE
FOR
THE
PREVENTION
OF
HEPATITIS
A:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
Y.
M
ORITSUGU
AND
D.
S
HOUVAL
.
505
TOWARD
ZERO
OCCURRENCE
OF
POST-TRANSFUSION
HEPATITIS:
SUMMARY
OF
A
SPECIALTY
SESSION
M.
S
HIMIZU
AND
P.V.
H
OLLAND
.
507
2.
VACCINE
HEPATITIS
A
VACCINE
DEVELOPMENT
IN
JAPAN
A.
T
OTSUKA
AND
Y.
M
ORITSUGU
.
509
REACTOGENICITY
AND
IMMUNOGENICITY
OF
A
COMBINED
HEPATITIS
A
AND
B
VACCINE
IN
HEALTHY
ADULTS
P.V.
D
AMME
,
S.
T
HOELEN
,
M.
C
RAMM
,
A.
S
AFARY
,
AND
A.
M
EHEUS
.
514
PREVENTION
OF
HEPATITIS
B
INFECTION
A.M.
P
RINCE
,
R.
M
AHONEY
,
AND
J.
M
AYNARD
.
517
PREVENTION
OF
HEPATITIS
B
IN
ASIA
T.
U
MENAI
,
T.
T
AKAHASHI
,
Y.
G
OTO
,
T.
A
KIBA
,
AND
N.
O
KABE
.
520
IMPLEMENTATION
OF
HEPATITIS
B
VIRUS
VACCINATION
IN
LATIN
AMERICA:
CURRENT
AND
FUTURE
PERSPECTIVE
OF
A
GLOBAL
ACTION
O.
F
AY
.
522
THE
IMMUNOGENICITY
AND
REACTOGENICITY
OF
COMBINED
TETRAVALENT
DIPHTERIA,
TETANUS,
PERTUSSIS
AND
HEPATITIS
B
VACCINE
IN
INFANTS
Y.
P
OOVORAWAN
,
A.
T
HEAMBOONLERS
,
S.
S
ANPAVAT
,
W.
P
ONGPUNLERT
,
S.
C
HUMDERMPADETSUK
,
A.
S
AFARY
,
AND
P.
V
ANDEPAPELI
6
RE
.
526
VERTICAL
TRANSMISSION
OF
HEPATITIS
B
VIRUS
AND
ITS
PREVENTION
IN
JAPAN
K.
S
HIRAKI
.
530
CLINICAL
TRIAL
OF
A
PRES2-CONTAINING
RECOMBINANT
HEPATITIS
B
VACCINE
Y.
A
KAHANE
.
533
THE
USE
OF
A
PRES2-CONTAINING
RECOMBINANT
VACCINE
FOR
THE
PREVENTION
OF
MATERNAL
TRANSMISSION
OF
HEPATITIS
B
VIRUS
IN
INDONESIAN
NEONATES
S.
S
UWIGNYO
,
I.G.P.
S
URYA
,
M
ULYANTO
,
M
ONTESSORI
,
K.
D
OMOTO
,
F.
T
SUDA
,
H.
O
KAMOTO
,
AND
S.
M
ISHIRO
.
536
XVIII
CONTENTS
CLINICAL
EXPERIENCE
WITH
THE
PRESL-CONTAINING
HEPATITIS
B
VACCINE
(HG-3)
IN
DIFFERENT
NON
RESPONDER
GROUPS
A.E.
H
EMMERLING
,
R.
M
ULLER
,
N.
F
IRUSIAN
,
J.
G
ROTZ
,
M.
H
AUBITZ
,
AND
H.A.
T
HOMA
.
540
IMMUNOGENICITY
OF
A
MAMMALIAN
CELL-DERIVED
RECOMBINANT
HEPATITIS
B
VACCINE
CONTAINING
PRES
2
AND
PRESJ
ANTIGENS:
A
PRELIMINARY
REPORT
D.
S
HOUVAL
,
Y.
I
LAN
,
A.
H
OURVITZ
,
R.
M
OSSERI
,
A.
S
OLOMON
,
C.
Z
YCHOWICZ
,
J.
G
ORNICKI
,
I.
C
ZUBKOWSKA
,
K.
M
ADALINSKI
,
B.
B
URCZYNSKA
,
R.
A
DLER
,
M.
G
ORECKI
,
AND
R.
K
OREN
.
543
VACCINATION
OF
HEPATITIS
E
VIRUS
T.
U
CHIDA
,
T.
S
HIKATA
,
T.
R
IKIHISA
,
M.
I
CHIKAWA
,
AND
K.
M
IZUNO
.
547
3.
POST-TRANSFUSION
HEPATITIS
POSTTRANSFUSION
HEPATITIS
IN
THE
UNITED
STATES
H.J.
A
LTER
.
551
PREVENTION
OF
POST-TRANSFUSION
HEPATITIS
IN
JAPAN
H.
Y
OSHIZAWA
.
554
TRANSFUSION-ASSOCIATED
HEPATITIS
(TAH)
IN
POLYTRANSFUSED
THALASSEMIC
CHILDREN
FOLLOWING
THE
INTRODUCTION
OF
ANTI-HCV
DONOR
SCREENING
IN
SARDINIA
M.E.
L
AI
,
F.
A
RGIOLU
,
P.
F
ARCI
,
V.
LISCI,
A.P.
M
AZZOLENI
,
C.
D
ESSI
,
A.
C
OIANA
,
M.B.
T
RONCI
,
S.
D
E
V
IRGILIS
,
M.
A
RNONE
,
A.
B
ALESTRIERI
,
AND
A.
C
AO
.
558
EFFECT
OF
DONOR
BLOOD
SCREENING
FOR
ANTI-HCV
ANTIBODY
BY
THE
SECOND-GENERATION
PASSIVE
HEMAGGLUTINATION
TEST
ON
THE
INCIDENCE
OF
POST-TRANSFUSION
HEPATITIS
K.
O
SADA
,
Y.
S
AMESHIMA
,
H.
F
UJII
,
M.
S
HIMIZU
,
J.
W
ATANABE
,
AND
K.
N
ISHIOKA
.
562
HEPATITIS
C
VIREMIA
AND
SEROLOGIC
PROFILE
IN
POST-TRANSFUSION
NON-A,
NON-B
HEPATITIS
A.
T
AGGER
,
M.L.
R
IBERO
,
F.
T
REMOLADA
,
C.
C
ASARIN
,
M.
R
APICETTA
,
K.
C
RISTIANO
,
M.
F
ASOLA
,
F.
P
REGLIASCO
,
ANDM.L.
P
ROFETA
.
565
PRESENCE
OF
DETECTABLE
HCV-RNA
IN
THE
ABSENCE
OF
POSITIVE
HCV
SEROLOGY
IN
BLOOD
DONORS
INFECTED
WITH
HTLV-I/II
M.
RIOS,
M.
D
URAN
,
M.
H
EMPSTEAD
,
P.
T
ULL
,
D.
K
ESSLER
,
AND
C.
B
IANCO
.
569
DETECTION
AND
QUANTITATION
OF
HCV-RNA
IN
IMMUNE
GLOBULINS
PRODUCED
BY
COHN-ONCLEY
FRACTIONATION
OF
HUMAN
PLASMA
M.W.
YU,
B.L.
M
ASON
,
S.
Y
EI
,
AND
D.L.
T
ANKERSLEY
.
574
IMMUNOGLOBULIN
SAFETY
RELATED
TO
TESTING
FOR
ANTIBODY
TO
HEPATITIS
C
VIRUS
R.
B
ISWAS
,
F.
M
ITCHELL
,
L.
W
ILSON
,
S.
N
EDJAR
,
J.
F
INLAYSON
,
AND D.
T
ANKERSLEY
.
578
TREATMENT
1.
INTERFERON
CYTOKINES
IN
THE
TREATMENT
OF
HUMAN
DISEASES:
INTRODUCTION
AND
SUMMARY
OF
A
PLENARY
SESSION
Y.
K
AWADE
.
583
CYTOKINES
IN
THE
TREATMENT
OF
HUMAN
DISEASE:
THE
INTERFERON
SYSTEM
-
FROM
THE
LABORATORY
TO
THE
CLINIC
C.E.
S
AMUEL
.
585
BASIC
RESEARCH
AND
CLINICAL
APPLICATION OF
NATURAL
INTERFERON-P:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
H.
S
UZUKI
.
591
TREATMENT
OF
HEPATITIS
C
WITH
INTERFERON:
MECHANISM
OF
ACTION
OF
INTERFERON
H.C.
T
HOMAS
AND
G.R.
F
OSTER
.
594
CONTENTS
XIX
A
RANDOMIZED,
CONTROLLED
TRIAL
OF
INTERFERON-
0
TREATMENT
FOR
ACUTE
HEPATITIS
C
M.
O
MATA
AND
S.
T
AKANO
.
601
OUTCOME
OF
ACUTE
HEPATITIS
C
AND
ROLE
OF
ALPHA
INTERFERON
THERAPY
A.
A
LBERTI
,
L.
C
HEMELLO
,
F.
B
ELUSSI
,
P.
P
ONTISSO
,
S.
T
ISMENETZKY
,
M.
G
EROTTO
,
F.
B
ARALLE
,
AND
P.
S
IMMONDS
.
604
TREATMENT
OF
CHRONIC
HEPATITIS
C
WITH
INTERFERON-A
S.
I
INO
,
K.
Y
ASUDA
,
S.
S
AINOKAMI
,
AND
K.
H
INO
.
607
CHANGES
IN
LEVELS
OF
HCV-RNA
AND
HEPATITIS
C
VIRAL
ANTIGEN
ASSOCIATED
WITH
INTERFERON
ALPHA
THERAPY
OF
CHRONIC
HEPATITIS
C
A.M.
DI
B
ISCEGLIE
,
M.
S
HINDO
,
K.
K
RAWCZYNSKI
,
AND
J.H.
H
OOFNAGLE
.
610
PREDICTORS
OF
ALPHA
INTERFERON
RESPONSE
IN
PATIENTS
WITH
CHRONIC
HEPATITIS
C
M.G.
R
UMI
,
R.
R
OMEO
,
AND
M.
C
OLOMBO
.
614
HIGH
VIRUS
TITER,
SLOW
VIRUS
DECREASE,
GENOTYPE
II,
AND
SEQUENCE
VARIABILITY
OF
E2/NS1HVR
PREDICT
POOR
RESPONSE
TO
INTERFERON
THERAPY
IN
CHRONIC
HEPATITIS
C
K.
C
HAYAMA
,
A.
T
SUBOTA
,
Y.
A
RASE
,
S.
S
AITOH
,
K.
I
KEDA
,
I.
K
OIDA
,
T.
M
ORINAGA
,
AND
H.
K
UMADA
.
617
MORE
REASONS
FOR
HOPE
IN
THE
THERAPY
OF
CHRONIC
HEPATITIS
C
C.
T
REPO
,
M.
C
HEVALLIER
,
N.
M
ANABE
,
D.
Q
U
,
X.
C
AUSSE
,
AND
L.
V
ITVTTSKI
.
621
BREAKTHROUGH
IN
CHRONIC
HEPATITIS
C
DURING
RECOMBINANT
ALPHA
INTERFERON
THERAPY
G.
C
OLLOREDO
,
L.
R
OFFI
,
G.
A
NTONELLI
,
G.
B
ELLATI
,
S.
D
EL
V
ECCHIO
,
G.
A
NGELI
,
G.
M
ANCIA
,
AND
F.
D
IANZANI
.
624
HEPATITIS
C
VIRAL
RNA
AND
HEPATIC
CYTOKINE EXPRESSION
IN
CHRONIC
HEPATITIS
C:
EFFECTS
OF
ALPHA
INTERFERON
THERAPY
M.
S
HINDO
,
J.H.
H
OOFNAGLE
,
AND
A.M.
D
I
B
ISCEGLIE
.
627
RELATIONSHIP
BETWEEN
SERUM
2-5AS
ACTIVITY
AND
THE
REDUCTION
OF
HCV-RNA
DURING
INTERFERON
THERAPY
Y.
K
ARINO
,
S.
H
IGE
,
A.
S
AGA
,
Y.
S
ASAKI
,
M.
T
SUYUGUCHI
,
T.
M
ATSUSHIMA
,
T.
M
IYAZAKI
,
Y.
O
KUUCHI
,
AND
J.
T
OYOTA
.
631
LONG-TERM
HISTOLOGIC
IMPROVEMENT
AND
PERSISTENT
HCV
REPLICATION
IN
PATIENTS
WITH
CHRONIC
HEPATITIS
C
HAVING
RESPONDED
TO
RECOMBINANT
ALPHA
INTERFERON
P.
M
ARCELLIN
,
N.
B
OYER
,
M.
M
ARTINOT
-P
EIGNOUX
,
J.
A
REIAS
,
E.
G
IOSTRA
,
C.
D
EGOTT
,
S.
E
RLINGER
,
AND
J.
-P.
B
ENHAMOU
.
635
INTERFERON
THERAPY
IN
CHRONIC
HEPATITIS
C
AND
LIVER
HISTOLOGY
K.
Y
ASUDA
,
K.
H
INO
,
S.
S
AINOKAMI
,
K.
K
AKU
,
AND
S.
I
INO
.
638
RIBAVIRIN
OR
ALPHA
INTERFERON
TREATMENT
OF
CHRONIC
HEPATITIS
C:
ASSESSMENT
OF
ANTIVIRAL
EFFICACY
S.
R
ASSAM
,
A.
R
IDLEY
-D
ASH
,
J.
W
ILBER
,
M.
U
RDEA
,
P.
N
EUWALD
,
S.
S
HERLOCK
,
N.
T
HOMPSON
,
N.
M
C
I
NTYRE
,
AND
G.
D
USHEIKO
.
642
2.
OTHERS
NON-INTERFERON
TREATMENT
OF
VIRAL
HEPATITIS:
ADDENDUM
TO
A
SUMMARY
OF
A
BREAKFAST
WORKSHOP
K.
F
UJISAWA
.
647
EFFECT
OF
THE
POLYSACCHARIDE
SIZOFIRAN,
AN
IMMUNOTHERAPEUTIC
AGENT,
ON
HBEAG-POSITIVE
CHRONIC
HEPATITIS
S.
K
AKUMU
,
K.
F
UJISAWA
,
H.
S
UZUKI
,
F.
I
CHIDA
,
S.
Y
AMAMOTO
,
C.
H
IRAYAMA
,
AND
N.
O
GAWA
.
650
CLINICAL
EFFECT
OF
AN
IMMUNOSTIMULANT
AGENT,
PROPAGERMANIUM,
IN
CHRONIC
HEPATITIS
B
M.
Y
ANO
.
654
XX
CONTENTS
EXPERIENCE
IN
GERMANY
WITH
GLYCYRRHIZINIC
ACID
FOR
THE
TREATMENT
OF
CHRONIC
VIRAL
HEPATITIS
E.
WLLDHIRT
.
658
THERAPEUTIC
APPROACH
TO
THE
CHRONIC
ACTIVE
LIVER
DISEASE:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
K.
F
UJISAWA
AND
B.N.
T
ANDON
.
662
HEPATOCELLULAR
CARCINOMA
1.
OVERVIEWS
CURRENT
ISSUES
IN
HEPATOCELLULAR
CARCINOMA:
HEPATITIS
B
VIRUS,
HEPATITIS
C
VIRUS,
AND
THE
P53
TUMOR
SUPPRESSOR
GENE:
SUMMARY
OF
A
PLENARY
SESSION
5
E.
T
ABOR
AND
K.
K
OBAYASHI
.
669
VIRAL
HEPATOCARCINOGENESIS:
ADDENDUM
TO
A
SUMMARY
OF
A
BREAKFAST
WORKSHOP
N.
H
ATTORI
.
672
TYPE
C
HEPATITIS
AND
HEPATOCELLULAR
CARCINOMA:
SUMMARY
OF
A
SPECIALTY
SESSION
T.
K
AMADA
.
674
VIRUS
AND
HOST
GENES
IN
HCC:
SUMMARY
OF
A
SPECIALTY
SESSION
K.
K
OIKE
.
676
CHEMOPREVENTION
OF
HEPATOCELLULAR
CARCINOMA:
SUMMARY
OF
A
SATELLITE
SYMPOSIUM
K.
O
KITA
AND
G.M.
W
ILLIAMS
.
679
2.
EPIDEMIOLOGY
EPIDEMIOLOGY
OF
HEPATOCELLULAR
CARCINOMA
M.C.
K
EW
.
681
HEPATITIS
B
AND
C
VIRUS
INFECTIONS
IN
HEPATOCELLULAR
CARCINOMA
AND
THEIR
PREVENTION
D.-S.
C
HEN
.
685
CHRONOLOGICAL
CHANGES
OF
HEPATITIS
B
AND
C
VIRUS
MARKERS
IN
JAPANESE
PATIENTS
WITH
HEPATOCELLULAR
CARCINOMA
K.
F
URUTA
,
K.
K
IYOSAWA
,
H.
S
ONE
,
A.
M
ATSUMOTO
,
E.
T
ANAKA
,
T.
S
ODEYAMA
,
H.
I
MAI
,
AND
S.
F
URUTA
.
690
HEPATITIS
B
AND
C
IN
PATIENTS
WITH
HEPATOCELLULAR
CARCINOMA
IN
BRAZIL
L.M.M.B.
P
EREIRA
,
S.
M
IES
,
W.
L
OSCHER
,
R.
M
UZKAT
,
E.H.
P
IROLLA
,
A.O.N.
F
ERNANDES
,
S.
R
AIA
,
M.G.
S
ALEH
,
C.J.
T
IBBS
,
LG.
M
C
F
ARLANE
,
AND
R.
W
ILLIAMS
.
694
ASSOCIATION
BETWEEN
HEPATITIS
B
AND
C
VIRUS
INFECTION
AND
CHINESE
HEPATOCELLULAR
CARCINOMA:
A
CASE-CONTROL
STUDY
J.-F.
T
SAI
,
H.S.
M
ARGOLIS
,
J.-E.
J
ENG
,
M.-S.
H
O
,
Y.-C.
K
O
,
Z.-Y.
L
IN
,
W.-Y.
C
HANG
,
AND
J.-H.
T
SAI
.
697
A
STUDY
OF
THE
PREVALENCE
OF
ANTI-HCV
IN
HEPATOCELLULAR
CARCINOMA
ASSOCIATED
WITH
CIRRHOSIS
D.
T
EMPESTA
,
D.
F
ORT
,
L.
M
ICHIELETTO
,
S.
B
IBIANI
,
G.
V
IANELLO
,
I.
A
NTONELLO
,
AND
M.
D
'
A
QUINO
.
701
ANTIBODY
PATTERN
OF
HCV
INFECTION
AND
HEPATOCELLULAR
CARCINOMA
IN
ITALY:
A
CASE
CONTROL
STUDY
M.
R
APICETTA
,
T.
S
TROFFOLINI
,
M.
C
HIARAMONTE
,
C.
T
IRIBELLI
,
E.
V
ILLA
,
R.G.
S
IMONETTI
,
M.
A.
S
TAZI
,
P.
C
HIONNE
,
T.
B
ERTIN
,
L.
C
ROCE
,
P.
T
RANDE
,
AND
A.
M
AGLIOCCO
.
703
HEPATITIS
C
VIRUS
INFECTION
AND
REPLICATION
IN
PATIENTS
WITH
HEPATOCELLULAR
CARCINOMA
L.
B
ENVEGNU
,
G.
F
ATTOVICH
,
G.
D
IODATI
,
F.
N
OVENTA
,
P.
P
ONTISSO
,
F.
T
REMOLADA
,
AND
A.
A
LBERTI
.
706
CLOSE
CORRELATION
BETWEEN
THE
RATE
OF
MORTALITY
DUE
TO
HEPATOCELLULAR
CARCINOMA
AND THE
CARRIER
RATE
OF
HCV,
ESPECIALLY
HCV
GENOTYPE
II
(OR
LB)
M.
Y
AMAUCHI
,
M.
N
AKAHARA
,
H.
N
AKAJIMA
,
J.
H
IRAKAWA
,
G.
T
ODA
,
AND
K.
F
UJISAWA
.
710
CONTENTS
XXI
TYPE
C
HEPATITIS
AND
HEPATOCELLULAR
CARCINOMA
IN
JAPAN
S.
T
ANAKA
.
713
3.
CARCINOGENESIS
MECHANISMS
OF
ACTIVATION
OF
CELLULAR
GENE
EXPRESSION
BY
INTEGRATED
HBV-DNA
R.
K
OSHY
.
717
THE
ROLE
OF
INTEGRATED
HEPADNAVIRUS
SEQUENCES
IN
HEPATOCELLULAR
CARCINOMA
P.
T
IOLLAIS
,
C.-A.
R
ENARD
,
Y.
W
EI
,
G.
F
OUREL
,
C.
T
RANSY
,
AND
M.A.
B
UENDIA
.
723
ANALYSIS
OF
HBV
INTEGRATION
SITES
IN
LIVER
TUMORS
WITHOUT
ACCOMPANYING
CIRRHOSIS
A.
M
ARCHIO
,
B.
T
ERRIS
,
P.
P
INEAU
,
Z.
T
U
,
E.
F
AGAN
,
P.
T
IOLLAIS
,
AND
A.
D
EIEAN
.
730
INTEGRATED
VIRAL
SEQUENCES
MAY
CONTRIBUTE
IN
CIS
AND
IN
TRANS
TO
HEPATOCARCINOGENESIS
IN
WOODCHUCK
HEPATITIS
VIRUS-INFECTED
WOODCHUCKS
Y.
W
EI
,
G.
F
OUREL
,
A.
P
ONZETTO
,
C.
T
REPO
,
P.
T
IOLLAIS
,
AND
M.-A.
B
UENDIA
.
734
MITOGENIC
ACTIVITY
OF
HEPATITIS
B
VIRUS
HBX
GENE
IN
VIVO
AND
IN
VITRO
K.
K
OIKE
,
K.
M
ORIYA
,
H.
Y
OTSUYANAGI
,
S.
I
INO
,
AND
K.
K
UROKAWA
.
738
DUAL
CONTROL
OF
HUMAN
HEPATITIS
B
VIRUS
X
PROTEIN
S.
M
URAKAMI
,
J.-H.
C
HEONG
,
K.
M
ATSUSHIMA
,
AND
S.
K
ANEKO
.
743
THE
API
TRANSCRIPTION
FACTOR
AS
A
MODEL
TO
STUDY
THE
MODULATION
OF
INTRACELLULAR
SIGNALLING
PATHWAYS
BY
THE
HEPATITIS
B
VIRUS
TRANSACTIVATOR
PX
G.
N
ATOLI
,
M.L.
A
VANTAGGIATI
,
C.
B
ALSANO
,
P.
C
HIRILLO
,
A.
C
OSTANZO
,
M.
A
RTINI
,
P.-L.
P
URI
,
A.
I
ANNI
,
AND
M.
L
EVRERO
.
748
CONTRIBUTION
OF
HBV
X
GENE EXPRESSION
TO
HEPATIC
CARCINOGENESIS
S.
T
AKADA
,
T.
M
ORI
,
H.
K
IDO
,
I.
N
AKAMURA
,
K.
Y
AGINUMA
,
N.
T
SUCHIDA
,
AND
K.
K
OIKE
.
753
RATE
OF
PERSISTENCE,
STRUCTURE,
AND
EXPRESSION
OF
HBV
GENOME
IN
HCC
DEVELOPING
IN
HBSAG-NEGATIVE
PATIENTS
P.
P
ATERLINI
,
K.
P
OUSSIN
,
A.
D
'
E
RRICO
,
S.
D
E
M
TRI
,
M.
K
EW
,
W.
G
RIGIONI
,
D.
F
RANCO
,
AND
C.
B
R
^
CHOT
.
757
LOSS
OF
TUMOR
SUPPRESSOR
GENES
IN
HCC
IN
JAPAN
AND
AUSTRALIA
S.
F
ALVEY
,
N.
H
AYWARD
,
AND
W.G.E.
C
OOKSLEY
.
763
DUCK
HEPATOCELLULAR
CARCINOMA
FROM
A
HIGH
INCIDENCE
AREA:
ANALYSIS
FOR
DUCK
HEPATITIS
B
VIRUS
INFECTION
AND
P53
MUTATION
A.
D
UFLOT
,
R.M
EHROTRA
,
M.
H
OLLSTEIN
,
C.P.
W
ILD
,
S.F.
C
AO
,
S.Z.
Y
U
,
M.
P
RAVE
,
R.
M
ONTESANO
,
C.
T
REPO
,
AND
L.
C
OVA
.
767
4.
DIAGNOSIS
AND
TREATMENT
IMAGE
DIAGNOSIS
OF
HEPATOCELLULAR
CARCINOMA
M.
O
HIO
,
M.
E
BARA
,
AND
H.
S
AISHO
.
771
NONINVASIVE
TREATMENT
FOR
HEPATOCELLULAR
CARCINOMA
K.
T
ANIKAWA
.
774
EPILOGUE
1.
WHERE
ARE
WE
GOING?
WHERE
ARE
WE
GOING?
-
TOWARD
CONTINUED
VICTORY
OVER
VIRUSES
T.
O
DA
.
781
FROM
HERE
TO
1996
M.
R
IZZETTO
.
782
JAZZ
AND
ALL
THAT
HCV:
"
FROM
MOLECULES
TO
MORE
CURES
"
S.
M
ISHIRO
.
783
XXII
CONTENTS
2.
APPENDIX
SOMETHING
PERHAPS
UNIQUE
TO
THE
1993
ISVHLD:
STATISTICS
AND
ACKNOWLEDGMENTS
S.
M
ISHIRO
,
K.
N
ISHIOKA
,
H.
S
UZUKI
,
AND
T.
O
DA
.
785
INDICES
1.
AUTHOR
INDEX
.
791
2.
KEY
WORD
INDEX
.
797 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV009610721 |
| callnumber-first | R - Medicine |
| callnumber-label | RC848 |
| callnumber-raw | RC848.H43 |
| callnumber-search | RC848.H43 |
| callnumber-sort | RC 3848 H43 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 5605 |
| ctrlnum | (OCoLC)30032030 (DE-599)BVBBV009610721 |
| dewey-full | 616.3/6230194 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.3/6230194 |
| dewey-search | 616.3/6230194 |
| dewey-sort | 3616.3 76230194 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV009610721</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160506</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">940516s1994 xx abd| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">941100421</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">354070132X</subfield><subfield code="9">3-540-70132-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">443170132X</subfield><subfield code="9">4-431-70132-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">038770132X</subfield><subfield code="9">0-387-70132-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30032030</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009610721</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC848.H43</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3/6230194</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 5605</subfield><subfield code="0">(DE-625)153237:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Viral hepatitis and liver disease</subfield><subfield code="b">proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD)</subfield><subfield code="c">ed. K. Nishioka ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Tokyo [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 802 S.</subfield><subfield code="b">Ill., graph. Darst., Kt.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carcinoma, Hepatocellular</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis Viruses</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral, Human</subfield><subfield code="x">diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral, Human</subfield><subfield code="x">epidemiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral, Human</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Leberkrankheit</subfield><subfield code="0">(DE-588)4034937-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hepatitisvirus</subfield><subfield code="0">(DE-588)4261165-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">Tokio</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Leberkrankheit</subfield><subfield code="0">(DE-588)4034937-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Hepatitisvirus</subfield><subfield code="0">(DE-588)4261165-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Leberkrankheit</subfield><subfield code="0">(DE-588)4034937-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nishioka, Kusuya</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Symposium on Viral Hepatitis and Liver Disease</subfield><subfield code="n">8</subfield><subfield code="d">1993</subfield><subfield code="c">Tokio</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2136686-X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006353025&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006353025</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1993 Tokio gnd-content |
| genre_facet | Konferenzschrift 1993 Tokio |
| id | DE-604.BV009610721 |
| illustrated | Illustrated |
| indexdate | 2024-11-22T17:06:09Z |
| institution | BVB |
| institution_GND | (DE-588)2136686-X |
| isbn | 354070132X 443170132X 038770132X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006353025 |
| oclc_num | 30032030 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 DE-188 |
| physical | XXII, 802 S. Ill., graph. Darst., Kt. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Springer |
| record_format | marc |
| spelling | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) ed. K. Nishioka ... Tokyo [u.a.] Springer 1994 XXII, 802 S. Ill., graph. Darst., Kt. txt rdacontent n rdamedia nc rdacarrier Literaturangaben Carcinoma, Hepatocellular Congresses Hepatitis Viruses physiology Congresses Hepatitis, Viral Congresses Hepatitis, Viral, Human diagnosis Congresses Hepatitis, Viral, Human epidemiology Congresses Hepatitis, Viral, Human therapy Congresses Leberkrankheit (DE-588)4034937-8 gnd rswk-swf Virushepatitis (DE-588)4290453-5 gnd rswk-swf Hepatitisvirus (DE-588)4261165-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1993 Tokio gnd-content Virushepatitis (DE-588)4290453-5 s Leberkrankheit (DE-588)4034937-8 s DE-604 DE-188 Hepatitisvirus (DE-588)4261165-9 s Nishioka, Kusuya Sonstige oth International Symposium on Viral Hepatitis and Liver Disease 8 1993 Tokio Sonstige (DE-588)2136686-X oth DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006353025&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) Carcinoma, Hepatocellular Congresses Hepatitis Viruses physiology Congresses Hepatitis, Viral Congresses Hepatitis, Viral, Human diagnosis Congresses Hepatitis, Viral, Human epidemiology Congresses Hepatitis, Viral, Human therapy Congresses Leberkrankheit (DE-588)4034937-8 gnd Virushepatitis (DE-588)4290453-5 gnd Hepatitisvirus (DE-588)4261165-9 gnd |
| subject_GND | (DE-588)4034937-8 (DE-588)4290453-5 (DE-588)4261165-9 (DE-588)1071861417 |
| title | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) |
| title_auth | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) |
| title_exact_search | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) |
| title_full | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) ed. K. Nishioka ... |
| title_fullStr | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) ed. K. Nishioka ... |
| title_full_unstemmed | Viral hepatitis and liver disease proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) ed. K. Nishioka ... |
| title_short | Viral hepatitis and liver disease |
| title_sort | viral hepatitis and liver disease proceedings of the international symposium on viral hepatitis and liver disease molecules today more cures tomorrow tokyo may 10 14 1993 1993 isvhld |
| title_sub | proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10 - 14, 1993 (1993 ISVHLD) |
| topic | Carcinoma, Hepatocellular Congresses Hepatitis Viruses physiology Congresses Hepatitis, Viral Congresses Hepatitis, Viral, Human diagnosis Congresses Hepatitis, Viral, Human epidemiology Congresses Hepatitis, Viral, Human therapy Congresses Leberkrankheit (DE-588)4034937-8 gnd Virushepatitis (DE-588)4290453-5 gnd Hepatitisvirus (DE-588)4261165-9 gnd |
| topic_facet | Carcinoma, Hepatocellular Congresses Hepatitis Viruses physiology Congresses Hepatitis, Viral Congresses Hepatitis, Viral, Human diagnosis Congresses Hepatitis, Viral, Human epidemiology Congresses Hepatitis, Viral, Human therapy Congresses Leberkrankheit Virushepatitis Hepatitisvirus Konferenzschrift 1993 Tokio |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006353025&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT nishiokakusuya viralhepatitisandliverdiseaseproceedingsoftheinternationalsymposiumonviralhepatitisandliverdiseasemoleculestodaymorecurestomorrowtokyomay101419931993isvhld AT internationalsymposiumonviralhepatitisandliverdiseasetokio viralhepatitisandliverdiseaseproceedingsoftheinternationalsymposiumonviralhepatitisandliverdiseasemoleculestodaymorecurestomorrowtokyomay101419931993isvhld |